maintenance

Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer

46% reduction in the risk of disease progression or death, and 27% reduction in the risk of death, in an…

5 months ago

DTX Group Debuts as Global Force, Powered by Strategic Vision and Independence Under Hussein Lookmanjee’s Leadership

Backed by years of preparation and a clear global strategy, DTX Group launches to capitalize on emerging market opportunities and…

5 months ago